Discover 1,106 paid clinical trials in Indiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
With many research studies being conducted across the state, Indiana provides opportunities for both healthy volunteers interested in paid studies and individuals with specific health needs. Research centers in Indianapolis, Fort Wayne, and South Bend are actively recruiting participants, granting access to advanced treatments and innovative healthcare.
Filter
1
Filter results
Results: 1,106
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
for
Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia ALL
Location: New York NY, Indianapolis IN, Houston TX, Fort Worth TX,
Sponsor: Allterum Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT07586618
Phase1, Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
for
Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus
Location: Boston MA, New Haven CT, Detroit MI, Atlanta GA,
Sponsor: Insulet Corporation
Sex: All
Age: 14 - 70+
Code: NCT07579702
Recruiting
Unilateral M1 Anodal tDCS to Enhance Learning in a Gross Movement Videogame Task
for
Motor Activity
Location: Indianapolis IN
Sponsor: Indiana University
Sex: All
Age: 18 - 45
Code: NCT07447882
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
for
Type 2 Diabetes Mellitus
Location: Boston MA, New York NY, Newport News VA, Syracuse NY,
Sponsor: Insulet Corporation
Sex: All
Age: 18 - 70+
Code: NCT07521475
Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
for
Macular Edema Secondary to Inflammation
Location: Boston MA, Waterford CT, Manchester CT, Greenwich CT,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06990399
Phase3, Recruiting
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
for
Severe Hypertriglyceridemia
Location: New Haven CT, New York NY, Montreal, Philadelphia PA,
Sponsor: Arrowhead Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06880770
Phase3, Recruiting
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
for
Prostate Cancer
Location: Plymouth MA, Providence RI, New York NY, Hackensack NJ,
Sponsor: AstraZeneca
Sex: Male
Age: 18+
Code: NCT06952803
Phase3, Recruiting
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
for
Primary Membranous Nephropathy
Location: Clifton Park NY, Orlando FL, Atlanta GA,
Sponsor: Climb Bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07096843
Phase2, Recruiting
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
for
Rhinovirus Infection
Location: Brooklyn NY, Hamilton NJ, Binghamton NY, Lutherville MD,
Sponsor: Altesa Biosciences, Inc.
Sex: All
Age: 40 - 70+
Code: NCT07610395
Phase2, Recruiting
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
for
Hematologic Neoplasms
Location: New York NY, Piscataway NJ, Grand Rapids MI,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07572006
Phase1, Recruiting
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
for
Peripheral Artery Disease (PAD)
Location: Mooresville NC, Crystal River FL, Knoxville TN,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07318610
Phase3, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for
Macular Edema Secondary to Inflammation
Location: Boston MA, Waterford CT, Manchester CT, Greenwich CT,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06996080
Phase3, Recruiting
rTMS Induced Reduction in M1 Excitability
for
Cortical Excitability, Primary Motor Cortex, Motor Skills
Location: Indianapolis IN
Sponsor: Indiana University
Sex: All
Age: 18 - 45
Code: NCT07588113
Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
for
Urothelial Cancer, Urinary Bladder Neoplasms
Location: Montreal, Norfolk VA, Newark DE, Fairfield OH,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07566156
Phase3, Recruiting
Comparative Assessment of Lipid Layer Thickness Measurements
for
Dry Eye
Location: Bloomington IN
Sponsor: Indiana University
Sex: All
Age: 18 - 70+
Code: NCT07579130
Recruiting
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: New York NY, Philadelphia PA, Sweetwater FL, Sanford FL,
Sponsor: Incyte Corporation
Sex: All
Age: 12 - 70+
Code: NCT07049575
Phase1, Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma